Everett E. Vokes to Platelet-Derived Growth Factor
This is a "connection" page, showing publications Everett E. Vokes has written about Platelet-Derived Growth Factor.
Connection Strength
0.128
-
Cisplatin, irinotecan, and bevacizumab for untreated extensive-stage small-cell lung cancer: CALGB 30306, a phase II study. J Clin Oncol. 2011 Nov 20; 29(33):4436-41.
Score: 0.102
-
Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107). Lung Cancer. 2012 Jun; 76(3):393-6.
Score: 0.026